X

Biotechnology

IPO News: Here’s what to know when Sera Prognostics goes public this week

The healthcare industry continues to grow at a rapid pace with diagnostic services playing an important role in this space.…

Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript

Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2021 earnings call dated Jun. 29, 2021 Corporate Participants: Tim Brons -- Executive Vice President, Vida…

Thermo Fisher (TMO) stock can add value to your portfolio. Here’s why

For Thermo Fisher Scientific Inc. (NYSE: TMO), a leading player in the medical diagnostics and life sciences market, 2020 was…

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for…

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding…

IPO News: What to look for when Elevation Oncology makes its Wall Street debut

The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that…

BeyondSpring, Inc.(BYSI) Q1 2021 Earnings Call Transcript

BeyondSpring, Inc. (NASDAQ: BYSI) Q1 2021 earnings call dated Jun. 16, 2021 Corporate Participants: Ashley R. Robinson -- Media & Investor Relations…

Is Merck (MRK) stock still a buy after losing the vaccine race?

After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the…

LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market?

For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges…

Bio-Path Holdings, Inc. (BPTH) Q1 2021 Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q1 2021 earnings call dated May. 14, 2021 Corporate Participants: Will O'Connor -- Investor Relations, Stern Investor…

ImmunoGen’s post-earnings dip could be a good buying opportunity

Earlier this week, biotech company ImmunoGen (NASDAQ: IMGN) reported mixed financial results for the first quarter of 2021, pushing the…

Veru Inc. (VERU) Q2 2021 Earnings Call Transcript

Veru Inc. (NASDAQ: VERU) Q2 2021 earnings call dated May. 12, 2021 Corporate Participants: Sam Fisch -- Director of Investor Relations Mitchell…

FibroGen Inc. (FGEN) Q1 2021 Earnings Call Transcript

FibroGen Inc. (NASDAQ: FGEN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Michael Tung -- Vice President of Corporate Strategy…

Immunogen, Inc. (IMGN) Q1 2021 Earnings Call Transcript

Immunogen, Inc. (NASDAQ: IMGN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications…

Regeneron Pharmaceuticals Inc. (REGN) Q1 2021 Earnings Call Transcript

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Justin Holko -- Vice President, Investor Relations…

Moderna (MRNA): COVID-19 vaccine helps company deliver first ever profitable quarter

Shares of Moderna Inc. (NASDAQ: MRNA) were down 3% in morning hours on Thursday despite the company reporting the first…

CVS Health gets a shot in the arm from COVID care: Is the stock a buy?

After being hit by the virus-induced slowdown in store footfall initially, CVS Health Corporation (NYSE: CVS) has regained the lost…

AbbVie (ABBV) Stock: Here’s what you need to know before investing

AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant's…

Biomarin Pharmaceutical Inc. (BMRN) Q1 2021 Earnings Call Transcript

Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Traci McCarty -- Vice President of Investor…

BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q1 financial results

Bristol-Myers Squibb Company (NYSE: BMY) reported first quarter 2021 earnings results today. Revenues increased 3% year-over-year to $11.1 billion. Net…

Infographic: How Biogen (BIIB) performed in Q1 2021

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today. Total revenues decreased 24% year-over-year to $2.6 billion. On…